Autopsy report · NCT03256045

Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

“Terminated due to loss of funding and former PI left the institution”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 3 years before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma

Interventions

Carfilzomib; Chemosensitivity Assay; Dexamethasone; Laboratory Biomarker Analysis; Panobinostat

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study
  “Study was terminated due to PI leaving the institution” (83% match in meaning)
• Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
  “Former PI Left the Institution” (80% match in meaning)
• Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
  “Terminated due to loss of funding” (79% match in meaning)
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
  “Due to PI leaving the institution” (78% match in meaning)
• Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
  “The PI retired/left the institution. Efforts were made to contact the PI but were unsuccessful.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.